Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration

OBJECTIVE(S): A new strategy in recent studies is using effective tuberculosis (TB) subunit vaccines combined with appropriate carriers and adjuvants which have shown promising results in preclinical and clinical studies. The aim of the present study was to evaluate the PLGA:DDA hybrid nanoparticles...

Descripción completa

Detalles Bibliográficos
Autores principales: Khademi, Farzad, Yousefi, Arshid, Derakhshan, Mohammad, Najafi, Adel, Tafaghodi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760476/
https://www.ncbi.nlm.nih.gov/pubmed/31579445
http://dx.doi.org/10.22038/ijbms.2019.33962.8079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760476/
https://www.ncbi.nlm.nih.gov/pubmed/31579445
http://dx.doi.org/10.22038/ijbms.2019.33962.8079

Ejemplares similares